Vitrolife Ab (STO:VITR) cover image
75 Reads (3 mins read)

Why Vitrolife Ab (STO:VITR) could be a stock to watch

29th May by Ben Hobson

Given widespread disruption and uncertainty in the stock market, it is more important than ever to find high quality stocks for your portfolio. That means safe, profitable companies with strong balance sheets.

We all like the idea of investing in the best quality companies. These multi-bagger stocks resist competitive threats and generate breathtaking profits, especially when the competition collapses. They compound investment returns at consistently above-average rates over the long term because they've got what billionaire investor Warren Buffett calls economic moats.

Here's a quick guide to what makes these stocks stand out - using {{links.nameAndTicker}}, which is active in the Healthcare Equipment & Supplies industry, as an example...

GET MORE DATA-DRIVEN INSIGHTS INTO STO:VITR »

How can you tell whether a company has a moat?

Before we get started on why this looks like a high quality stock, here are some of the main ways that a company can build a strong moat around itself:

  • Intangible Assets - Such as brands that customers love, valuable patents or regulatory approval
  • Switching Costs - It might be too costly, complicated or unnecessary for customers to look elsewhere
  • Network Effects - When customers become part of a product it creates tremendously powerful businesses
  • Cost Advantages - Superior processes and unique locations and assets make it hard for others to compete
  • Great Scale - Large infrastructure and distribution networks are powerful barriers to entry in many industries

So, has Vitrolife Ab (STO:VITR) got a moat?

When it comes to finding companies with moats, some of the biggest clues actually lie in their financial statements. By looking at a small number of important ratios you can get an idea about the competitive strength and profit power in a business.

Here's what they are and why they are important - and how Vitrolife Ab stacks up against them:

  1. High rates of Free Cash Flow - the measure of a thriving company.
    - A high ratio of free cash flow to sales can be a very positive sign. For Vitrolife Ab, the figure is an impressive 21.0%. 
  2. High Return on Capital Employed - the measure of a company growing efficiently and profitably.
    - A 5-year average ROCE of more than 12 percent is a pointer to strong efficiency. For Vitrolife Ab, the figure is an eye-catching 24.9%.
  3. High Return on Equity (compared to peers) - the measure of a company making good profits from its assets.
    - Vitrolife Ab has a 5-year average ROE of 22.7%.
  4. High Operating Margins (compared to peers) - the measure of a company with pricing power
    - Vitrolife Ab has a 5-year average operating margin of 32.0%.

What does this mean for potential investors?

Some of the best quality stocks in the market have defensible models that can deliver high levels of shareholder returns over the long term. But there are no guarantees and it's important to do your own research. Indeed, we've identified some areas of concern with Vitrolife Ab that you can find out about here.

Alternatively, if you'd like to find more shares that have some of the characteristics of promising economic moats, you should take a look at this Economic Moats screen.

Share this article
As per our Terms of Use, Stockopedia is a financial news & data site, discussion forum and content aggregator. Our site should be used for educational & informational purposes only. We do not provide investment advice, recommendations or views as to whether an investment or strategy is suited to the investment needs of a specific individual. You should make your own decisions and seek independent professional advice before doing so. Remember: Shares can go down as well as up. Past performance is not a guide to future performance & investors may not get back the amount invested.
Share Price
SEK242.6
Change Today
0.17%
Vitrolife Ab ( )

Stockopedia is here to help individual investors beat the markets by being the very best in stock analysis, research & community. Take a 30 day free trial of our extensive multi-award winning service and find out why more than ten thousand global investors can't live without it.

© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.